NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...

A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key ...

A new AI tool called RibbonFold is revolutionizing how scientists understand misfolded proteins linked to Alzheimer’s and Parkinson’s.

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key ...

The amyloid beta oligomers quickly formed ... The team also plans to explore the effectiveness on NU-9 in other neurodegenerative diseases, like Parkinson's disease and Huntington's disease.

While beta-amyloid plaques are still an addition to the causes of neurodegenerative disease, recent studies show that tau ...

A comprehensive review explores how gut microbiota diversity and fitness influence Alzheimer’s disease (AD) risk through ...

The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease (PD) and anti-tau therapies, which are ...

Johnson et al, Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of ...